CCL5 Inhibits Elevation of Blood Pressure and Expression of Hypertensive Mediators in Developing Hypertension State Spontaneously Hypertensive Rats

목차 (Table of Contents)

• INTRODUCTION
• MATERIALS AND METHODS
• RESULTS
• DISCUSSION
• REFERENCES

참고문헌 (Reference)

1 Leiper JM, "Whitley GS, et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases" 343 : 209-214, 1999

2 Cruzado MC, "Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation" 18 : 81-87, 2005

3 Schiffrin EL, "Vascular endothelin in hypertension" 43 : 19-29, 2005

4 Widdop RE, "Vascular angiotensin AT2 receptors in hypertension and ageing" 35 : 386-390, 2008

5 Vaziri ND, "Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats" 31 : 1248-1254, 1998

6 Kim HY, "Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats" 31 : 515-523, 2008

7 Alexander RW, "Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective" 25 : 155-161, 1995

8 Inoue A, "The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes" 86 : 2863-2867, 1989

9 De Paolis P, "Savoia C, et al. Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells" 17 : 1873-1877, 1999

10 Agapitov AV, "Role of endothelin in cardiovascular disease" 3 : 1-15, 2002

11 Deji N, "Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension" 418 : 559-564, 2012

12 Reddy MA, "Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells" 29 : 387-393, 2009

13 Preston IR, "Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation" 290 : L367-L374, 2006

14 Kim HY, "Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats" 34 : 120-127, 2011

15 Ueda S, "Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase" 92 : 226-233, 2003

16 Natarajan R, "Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells" 30 : 873-879, 1997

17 Tripathy D, "RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role" 31 : 8-16, 2010

18 Shahrara S, "RANTES modulates TLR4-induced cytokine secretion in human peripheral blood monocytes" 177 : 5077-5087, 2006

19 Zoja C, "Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation" 53 : 1608-1615, 1998

20 Mallat Z, "Protective role of interleukin-10 in atherosclerosis" 85 : e17-e24, 1999

21 Navratilova Z, "Polymorphisms in CCL2 & CCL5 chemokines/chemokine receptors genes and their association with diseases" 150 : 191-204, 2006

22 Capers Q, "Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats" 30 : 1397-1402, 1997

23 Kashiwagi M, "MCP-1 and RANTES are expressed in renal cortex of rats chronically treated with nitric oxide synthase inhibitor. Involvement in macrophage and monocyte recruitment" 92 : 165-173, 2002

24 Gerszten RE, "MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions" 398 : 718-723, 1999

25 Kassan M, "Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice" 31 : 2534-2542, 2011

26 Nozawa K, "Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats" 259 : H1774-H1780, 1990

27 González-Núñez D, "Increased levels of 12(S)-HETE in patients with essential hypertension" 37 : 334-338, 2001

28 Usui M, "Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats" 101 : 305-310, 2000

29 김정혜, "IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats" 대한면역학회 9 (9): 106-113, 2009

30 Kim HY, "IL-10 up-regulates CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats" 68 : 40-49, 2014

31 Gunnett CA, "IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation" 279 : H1555-H1562, 2000

32 Jei-Jun Bae, "Expression of Endothelin-1 by Stimulation with CXCL8 in Mouse Peritoneal Macrophages" 대한미생물학회 39 (39): 205-216, 2009

33 Chou SY, "Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes" 28 : 3277-3290, 2008

34 Sasaki M, "Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat" 10 : 371-378, 1997

35 Buemi M, "Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension" 20 : 19-24, 2004

36 Kim HY, "Effect of CCL5 on dimethylarginine dimethylaminohydrolase-1 production in vascular smooth muscle cells from spontaneously hypertensive rats" 64 : 227-233, 2013

37 김정해, "Downregulation of Angiotensin II-Induced 12-Lipoxygenase Expression and Cell Proliferation in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats by CCL5" 대한약리학회 13 (13): 385-392, 2009

38 Wadham C, "Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease" 5 : 303-319, 2009

39 Palm F, "Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems" 293 : H3227-H3245, 2007

40 Dumont Y, "D'Amours M, Lebel M, Larivière R. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats" 19 : 1479-1487, 2001

41 Dhungana S, "Cytokines and chemokines in idiopathic intracranial hypertension" 49 : 282-285, 2009

42 Ishibashi M, "Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocyte in hypertension-induced vascular inflammation and remodeling" 94 : 1203-1210, 2004

43 Dilek N, "Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5" 188 : 4209-4216, 2012

44 Dorfmüller P, "Chemokine RANTES in severe pulmonary arterial hypertension" 165 : 534-539, 2002

45 Kim HY, "CCL5 upregulates activation of AMP-activated protein kinases in vascular smooth muscle cells of spontaneously hypertensive rats" 67 : 77-84, 2014

46 Montecucco F, "CC chemokine CCL5 plays a central role impacting infarct size and postinfarction heart failure in mice" 33 : 1964-1974, 2012

47 Merched AJ, "Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators" 22 : 3595-3606, 2008

48 Achan V, "Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase" 23 : 1455-1459, 2003

49 Chen XL, "Angiotensin ll induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells" 83 : 952-959, 1998

50 Jin XQ, "Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells" 39 : 1021-1027, 2002

51 Wolf G, "Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors" 61 : 1986-1995, 2002

52 Fukuda S, "Age-related changes in blood pressure, hematological values, concentrations of serum biochemical constituents and weights of organs in the SHR/Izm" 53 : 67-72, 2004

53 Siragy HM, "AT(1) and AT(2) receptors in the kidney: role in disease and treatment" 36 : 4-9, 2000

54 Nagata D, "AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation" 110 : 444-451, 2004

55 Ford RJ, "AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats" 30 : 725-733, 2012

56 Teng RJ, "AMP kinase activation improves angiogenesis in pulmonary artery endothelial cells with in utero pulmonary hypertension" 304 : L29-L42, 2013

57 Banek CT, "AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat" 304 : H1159-H1165, 2013